Home / Genomic Tests / Liquid Trace on CSF
LIQUID TRACE / CSF

Liquid Trace
on CSF

cfDNA + cfRNA Liquid Biopsy for CNS Disease

Beyond Blood. Closer to CNS Disease.

Profile molecular signals in cerebrospinal fluid for primary brain tumors, CNS metastases and hematologic malignancies involving the CNS.

Conceptual patient portrait with DNA and RNA molecular imagery
Conceptual image
The essentials

Testing at a Glance

cfDNAGenomic alterations
cfRNAGene-message information
CSFCerebrospinal fluid
CNSSolid & hematologic disease

Explore CNS Conditions

Primary Brain Tumors — Explore testing in the context of the diagnosis, prior results and the clinical question.

View GTC’s Cancer & Testing Directory ↗
Complementary molecular insights

Why Evaluate Both cfDNA and cfRNA?

The source of a liquid biopsy matters. CSF can provide a different view of CNS disease from a blood sample. Evaluating both cfDNA and cfRNA adds complementary molecular information from that compartment.

cfDNA

Cell-free DNA consists of DNA fragments outside intact cells. Tumor-associated alterations in those fragments can provide genomic information.

  • Sequence alterations
  • Copy number and chromosomal findings
  • Genomic context for interpretation

cfRNA

Cell-free RNA adds information about gene messages. It can contribute evidence about expressed fusions, gene expression and abnormal splicing.

  • Expressed gene fusions
  • Expression patterns
  • Splice-related information

Different Signals. An Integrated Interpretation.

RNA abundance and molecular shedding vary. The value of the combined profile comes from evaluating complementary findings together—not from assuming every sample contains every signal.

For clinicians

Insights That Support Clinical Decisions

Review molecular evidence in the context of diagnosis, treatment history and the complete clinical workup.

Conceptual CNS anatomy with lymphoma-like cells and molecular signals
01 / UNDERSTAND

CNS Molecular Profiling

Evaluate molecular signals from the compartment surrounding the brain and spinal cord.

Conceptual molecular illustration
02 / EVALUATE

Solid & Hematologic Disease

Review genomic and RNA findings, with lymphoid clonality information where relevant.

Conceptual molecular illustration
03 / INTEGRATE

Treatment & Monitoring Context

Bring molecular findings into discussions of therapy, clinical trials and follow-up assessment.

Conceptual scientific illustrations.

Why the Specimen Matters

CSF samples the central nervous system compartment. For CNS-confined disease, it may provide tumor-derived information that is difficult to detect in plasma. The amount of material available varies between patients.

Support a Multimodal Workup

CSF molecular profiling is considered alongside imaging, cytology, flow cytometry, tissue pathology and clinical findings. No single test resolves every diagnostic question.

Evaluate Lymphoid Disease

Mutation and RNA findings can be interpreted with B- and T-cell clonality in appropriate CNS lymphoma or leukemia evaluations. A result must be assessed in the complete diagnostic context.

Consider MGMT as an Add-On

GTC offers MGMT promoter methylation analysis for brain-tumor evaluations when tumor DNA is detected. Discuss suitability and ordering with the laboratory.

The molecular story

Beyond Blood. Closer to CNS Disease.

cfDNA + cfRNA

Beyond Blood.

The clinical question may call for a different sampling compartment.

Conceptual molecular storytelling illustration

Select a scene to explore the story. These are conceptual visuals, not patient results.

Conceptual illustration of lymphoma-like cells, CNS anatomy and CSF-associated DNA and RNA
Conceptual neuro-oncology illustration · CNS disease and the CSF compartment

Sample the Relevant Compartment

CSF can add a CNS-focused molecular perspective. It complements the other studies chosen by the clinical team; the choice to collect CSF depends on the patient’s circumstances.

For patients & families

Understanding CSF Liquid Biopsy

Cerebrospinal fluid, or CSF, surrounds the brain and spinal cord. Your doctor may recommend testing it to learn more about a cancer affecting the central nervous system.

How is the sample collected?

A trained clinical team collects CSF, usually through a lumbar puncture or an existing reservoir. Your doctor will explain the procedure and whether it is appropriate.

Will this identify a treatment?

The test may inform treatment discussions, but a treatment match is not guaranteed. Your doctor will explain what the findings mean for you.

What if the result is negative?

A negative result does not rule out cancer. Your care team will consider other test results and whether further evaluation is needed.

Testing is ordered through your treating clinician. Discuss suitability and collection with your care team.

Getting started

Sample Requirements & Ordering

A clear path from selecting the test to submitting the specimen.

Select Testing

Choose Liquid Trace on CSF and complete the requisition.

Arrange CSF Collection

The clinical team selects and collects an appropriate specimen.

Submit the Specimen

Include relevant clinical information and follow GTC’s shipping instructions.

CSF collection

Cerebrospinal Fluid

GTC lists 7–10 mL as optimal and 5 mL as the minimum for CSF on its Liquid Trace collection pages. Use a clear collection tube without anticoagulant and arrange prompt overnight shipment. Confirm current instructions before collection.

Ready to Arrange Testing?

Get collection instructions and help choosing the right test.

Your questions, answered

Frequently Asked Questions

How does this differ from DNA-only liquid biopsy?

Liquid Trace evaluates cfDNA and cfRNA. RNA contributes gene-message information that complements the genomic findings from DNA.

Does this replace other diagnostic tests?

No single test answers every clinical question. The treating team may use liquid biopsy with tissue pathology, imaging and other studies.

How long do results take?

Contact GTC to confirm the current turnaround time for the selected assay, specimen and clinical circumstances.

How do I order testing?

Use GTC’s ordering resources or call 866-484-8870. Patients should work with their treating clinician.

Turn Molecular Insight Into a More Informed Conversation

Discuss the right specimen and test for the clinical question.

Contact GTC ↗